CYTR Related Momentum Movers
-
CytRx (CYTR) Sinks Following 39.2M Common Offering, Warrant Pricing
-
CytRx (CYTR) Said Leukemia Patient Achieves Complete Remission After Treatment
-
SNSS, CYTR, OSIP, HBAN, JASO, BAC, GS See Volume and Upside Price Action
-
CytRx (CYTR) INNO-206 Shows Dramatic Destruction of Implanted Tumors In Animal Model
-
DCGN, CYTR, IOC, TRW, SVA, WEN See Volume and Upside Price Action
-
HTZ, JAZZ, TWB, CAEI, CYTR See Volume and Upside Price Action
-
CYTR, SVNT, AGEN, ALVR See Volume and Upside Price Action
-
CytRx (CYTR) Said Tamibarotene Showed Statistically Significant Anti-Tumor Activity
-
CytRx (CYTR) Sees Upside On Positive Call from "CNBC Champ"
-
CytRx (CYTR) Higher on 'CNBC Champ' Recommendation
-
CytRx Corp. (CYTR) re-opens for trading following royalty news. Stock up 34%
Back to CYTR Stock Lookup
